IL92316A0 - Recombinant interleukin-2 hybrid proteins,their production and pharmaceutical compositions containing them - Google Patents

Recombinant interleukin-2 hybrid proteins,their production and pharmaceutical compositions containing them

Info

Publication number
IL92316A0
IL92316A0 IL92316A IL9231689A IL92316A0 IL 92316 A0 IL92316 A0 IL 92316A0 IL 92316 A IL92316 A IL 92316A IL 9231689 A IL9231689 A IL 9231689A IL 92316 A0 IL92316 A0 IL 92316A0
Authority
IL
Israel
Prior art keywords
production
pharmaceutical compositions
compositions containing
hybrid proteins
recombinant interleukin
Prior art date
Application number
IL92316A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL92316A0 publication Critical patent/IL92316A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL92316A 1988-11-17 1989-11-15 Recombinant interleukin-2 hybrid proteins,their production and pharmaceutical compositions containing them IL92316A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27235688A 1988-11-17 1988-11-17

Publications (1)

Publication Number Publication Date
IL92316A0 true IL92316A0 (en) 1990-07-26

Family

ID=23039446

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92316A IL92316A0 (en) 1988-11-17 1989-11-15 Recombinant interleukin-2 hybrid proteins,their production and pharmaceutical compositions containing them

Country Status (13)

Country Link
EP (1) EP0369316A3 (de)
JP (1) JPH02273193A (de)
AU (1) AU4474589A (de)
CA (1) CA2002854A1 (de)
DK (1) DK570589A (de)
FI (1) FI895456A0 (de)
HU (1) HUT52154A (de)
IL (1) IL92316A0 (de)
MC (1) MC2072A1 (de)
NO (1) NO894573L (de)
PT (1) PT92335A (de)
YU (1) YU219289A (de)
ZA (1) ZA898139B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69019609T2 (de) * 1989-07-07 1995-11-30 Takeda Chemical Industries Ltd Proteine und deren Herstellung.
FR2653020B1 (fr) * 1989-10-17 1993-03-26 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des leucemies.
US5273889A (en) * 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
EP0547163B1 (de) * 1990-08-29 2002-02-06 Centre Hospitalier Regional De Nantes An stabile proteinkernstruktur gebundene proteinpolyliganden
US5571507A (en) * 1992-02-25 1996-11-05 Seragen, Inc. Methods of treating diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210634A (en) * 1983-12-23 1989-05-29 Hoffmann La Roche Purification of recombinant human interleukin - 2; pharmaceutical compositions
DE3537461A1 (de) * 1985-10-22 1987-04-23 Hoechst Ag Derivat des interleukin-2, seine herstellung und verwendung
US4892827A (en) * 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects

Also Published As

Publication number Publication date
YU219289A (en) 1991-10-31
JPH02273193A (ja) 1990-11-07
AU4474589A (en) 1990-05-24
PT92335A (pt) 1990-05-31
NO894573D0 (no) 1989-11-16
EP0369316A3 (de) 1990-11-22
MC2072A1 (fr) 1990-10-03
DK570589D0 (da) 1989-11-14
NO894573L (no) 1990-05-18
ZA898139B (en) 1990-08-29
EP0369316A2 (de) 1990-05-23
HUT52154A (en) 1990-06-28
CA2002854A1 (en) 1990-05-17
DK570589A (da) 1990-05-18
FI895456A0 (fi) 1989-11-16
HU895908D0 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
IL89881A0 (en) Peptide derivatives,their production and pharmaceutical compositions containing them
IL85136A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
IL90550A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL92518A0 (en) Aminobenzoates,their preparation and pharmaceutical compositions containing them
IL89427A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL72572A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IL74681A0 (en) Cyclosporins,their production and pharmaceutical compositions containing them
NZ213563A (en) Anticoagulant proteins and pharmaceutical compositions
IL95503A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL77294A (en) 2-piperazino-4,7-di(cyclo)amino piperidine derivatives,their preparation and pharmaceutical compositions containing them
GB2171103B (en) Novel peptides and peptide derivatives, their preparation and use and pharmaceutical compositions containing them
IL71951A0 (en) Polypeptides having interferon activity,their preparation and pharmaceutical compositions containing them
IL86876A0 (en) Polypeptides,their preparation and pharmaceutical composition containing them
IL85885A0 (en) Cyclic peptides,their preparation and pharmaceutical compositions containing them
HUT58107A (en) Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
IL87871A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL72219A0 (en) Peptides,their production and pharmaceutical compositions containing them
IL88927A0 (en) Thienoazepines,their production and pharmaceutical compositions containing them
IL92316A0 (en) Recombinant interleukin-2 hybrid proteins,their production and pharmaceutical compositions containing them
IL91003A0 (en) Proteins,their production and pharmaceutical compositions containing them
IL79858A0 (en) Peptide antibiotics,their preparation and compositions containing them
IL69540A0 (en) Polypeptides,their production and pharmaceutical compositions containing them
IL81355A0 (en) 8alpha-acylaminoergolines,their production and pharmaceutical compositions containing them
IL88934A0 (en) Recombinant human interleukin-1alpha polypeptides,their preparation and pharmaceutical compositions containing them